| Mrs Nina Marie Garner, CST/CSFA | |
|
2221 Elm St, Rawlins, WY 82301-5108 | |
| (307) 324-8270 | |
| Not Available |
| Full Name | Mrs Nina Marie Garner |
|---|---|
| Gender | Female |
| Speciality | Surgery |
| Location | 2221 Elm St, Rawlins, Wyoming |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245986850 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 208217 (Wyoming) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Nina Marie Garner, CST/CSFA 1621 Inverness Blvd, Rawlins, WY 82301-4580 Ph: (130) 732-1804 | Mrs Nina Marie Garner, CST/CSFA 2221 Elm St, Rawlins, WY 82301-5108 Ph: (307) 324-8270 |
News Archive
Children born to women who were exposed to higher arsenic during pregnancy have a greater risk of infections and respiratory symptoms within their first year of life, a Dartmouth College-led study shows.
A California legislative committee gave preliminary approval Tuesday to a bill that would tighten security at hospitals and increase their requirements for reporting violent acts to the state.
Scientists at the University of North Carolina at Chapel Hill School of Medicine have discovered a gene that when mutated causes obesity by dampening the body's ability to burn energy while leaving appetite unaffected.
From street outreach in Burlington, Vermont to a New York City taxi network to infant mortality prevention in Detroit, ten hospital programs were named Programs of Excellence for their achievements in improving the health of local communities. Each program was awarded $10,000 through the Hospital Charitable Services Awards, a national program sponsored by Jackson Healthcare.
Despite the promising findings of the PROTECT Pilot study, the larger PROTECT trial found no difference with rolofylline versus placebo with respect of the primary and main secondary end-points of the study. Although more rolofylline patients than placebo patients experienced moderate or marked dyspnea improvement at 24 and 48 hours from randomization, this was counterbalanced by a lack of effect on persistent renal impairment. Lastly, the risk of important neurological events was increased in patients on rolofylline.
› Verified 5 days ago
John C Lumb, MD Surgery Medicare: Medicare Enrolled Practice Location: 2221 Elm St, Rawlins, WY 82301 Phone: 307-324-2221 | |
Palur V. Sridharan, M.D.,F.A.C.S.,F.I.C. Surgery Medicare: Medicare Enrolled Practice Location: 519 8th St, Rawlins, WY 82301 Phone: 307-324-2705 Fax: 307-324-2923 |